Frequency of BP medications/combination use among all patients
| . | Patients on the drug class N = 118, % . | Days on treatment (median) . |
|---|---|---|
| Anti-HTN class∗ | ||
| ACEi/ARB | 66 | 722 |
| CCB | 51 | 482 |
| BB | 36 | 1036 |
| HCTZ | 29 | 690 |
| BP drug combinations∗ | ||
| ACEi/ARB + HCTZ | 20 | |
| CCB + HCTZ | 11 | |
| BB + HCTZ | 8 | |
| ACEi/ARB + CCB | 27 | |
| Number of BP drugs prescribed at a time | ||
| 1 | 39 | |
| 2 | 40 | |
| 3 | 16 | |
| ≥4 | 5 |
| . | Patients on the drug class N = 118, % . | Days on treatment (median) . |
|---|---|---|
| Anti-HTN class∗ | ||
| ACEi/ARB | 66 | 722 |
| CCB | 51 | 482 |
| BB | 36 | 1036 |
| HCTZ | 29 | 690 |
| BP drug combinations∗ | ||
| ACEi/ARB + HCTZ | 20 | |
| CCB + HCTZ | 11 | |
| BB + HCTZ | 8 | |
| ACEi/ARB + CCB | 27 | |
| Number of BP drugs prescribed at a time | ||
| 1 | 39 | |
| 2 | 40 | |
| 3 | 16 | |
| ≥4 | 5 |
Indicates the percentage of patients taking this class or combination of alone or with other categories.